The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAgronomics Regulatory News (ANIC)

Share Price Information for Agronomics (ANIC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.20
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.10 (1.176%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 8.20
ANIC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Meatly Creates Cans of Cultivated Pet Food

18 Mar 2024 07:00

RNS Number : 1402H
Agronomics Limited
18 March 2024
 

18 March 2024

Agronomics Limited

("Agronomics" or the "Company")

Meatly Creates the World's First Cans of Cultivated Pet Food Through Partnership

with Omni

 

Agronomics (LSE: ANIC), a leading listed company focused on the field of cellular agriculture, is pleased to announce that portfolio company Good Dog Food Ltd (trading as "Meatly") has created the world's first cans of pet food that use cultivated chicken as a protein source. The product was created in collaboration with Meatly's first brand partner Omni Pet Ltd ("Omni"), a fast-growing novel protein pet food company in the UK, founded by veterinarian Dr Guy Sandelowsky.

 

Omni has achieved more than £2 million in sales to date selling dog food crafted from pulse, algae and yeast protein. The use of Meatly's cruelty-free chicken ingredient marks an important step in the mission of both companies to offer ethical and more environmentally friendly and healthy products for pets.

 

Once its product has been granted regulatory approval, Meatly-produced pet food will be made available in shops across the country through partnerships with retailers and manufacturers like Omni. As an early investor in Meatly, Pets at Home Limited plans to be the first retailer to offer these products in its stores.

 

Formerly known as 'Good Dog Food', the cultivated meat company rebranded as Meatly in November 2023 and has been working with the UK's Food Standards Agency and the Department for Environment Food & Rural Affairs to obtain approval for its cultivated chicken pet food to become available to buy in the UK.

 

Owen Ensor, Co-founder and CEO of Meatly, said:

 

"It is incredibly exciting to see the first ever cans of cultivated pet food fly off the production line. This is a major milestone for cultivated meat globally and shows that we are ready to sell product."

 

"As demand continues to grow, with pet food already accounting for 20% of meat produced globally, so too

does the industry's environmental impact. Cultivated meat gives pet parents an easy choice - high-quality,

tasty, nutritious, and sustainable pet food. We're thrilled to work with innovative companies like Omni to

make this a reality as soon as possible."

 

Jim Mellon, Agronomics' Executive Chairman added:

 

"This partnership shows the rapid progress Meatly has made in a very short period of time. Founded only 2 years ago, and with minimal capital, the company has now demonstrated it is ready to bring its product to market with key partners in the pet food industry. While regulatory approval has taken longer than anticipated, we are optimistic that Meatly's work with the governing authorities will be able to accelerate the timeline and launch its product shortly after."

 

About Meatly

Meatly (previously known as Good Dog Food) was founded in 2022 by CEO Owen Ensor and CSO Dr Helder Cruz

with backing from investor Agronomics. The company produces ethical and sustainable cultivated meat products

without compromising on essential nutritional benefits. Its current focus is on the pet food market. Learn more at http://meatly.pet.

 

About Agronomics

Agronomics is a leading listed company focussing on investment opportunities within the field of cellular agriculture. The Company has established a portfolio of over 20 companies in this rapidly advancing sector. It seeks to invest in companies owning technologies with defensible intellectual property that offer new ways of producing food and ingredients with a focus on products historically derived from animals. These technologies are driving a major disruption in agriculture, offering solutions to improve sustainability and address human health, food security, and animal welfare. A full list of Agronomics' portfolio companies is available at https://agronomics.im/.

 

 

Agronomics

Limited

Beaumont

Cornish Limited

Canaccord Genuity Limited

Cavendish Capital Markets Limited

Peterhouse Capital

Limited

SEC Newgate

The Company

Nomad

Joint Broker

Joint Broker

Joint Broker

Public Relations

Jim Mellon

Denham Eke

Roland Cornish

James Biddle

Andrew Potts

Harry Pardoe

Alex Aylen

Giles Balleny

Michael Johnson

Charlie Combe

Lucy Williams

Charles Goodfellow

Bob Huxford Anthony Hughes

+44 (0) 1624 639396

info@agronomics.im

+44 (0) 207 628 3396

+44 (0) 207 523 8000

+44 (0) 207 397 8900

+44 (0) 207 469 0936

agronomics@secnewgate.co.uk

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAUBVKRSAUOARR
Date   Source Headline
4th Dec 20197:00 amRNSUpdate on Placing and Final Results
11th Nov 20197:00 amRNSProposed Fundraise
29th Oct 20197:00 amRNSInvestment in Shiok Meats Pte. Ltd.
22nd Oct 20192:00 pmRNSCompany Newsletter
17th Oct 20197:00 amRNSInvestment in VitroLabs Inc
15th Oct 20197:00 amRNSInvestment in Rebellyous Foods
8th Oct 20197:00 amRNSNet Asset Value(s)
23rd Sep 20191:00 pmRNSAIM Rule 17 Notification
12th Sep 20197:00 amRNSInvestee Company Update
9th Sep 201911:55 amRNSHolding(s) in Company
5th Sep 20197:00 amRNSSeed Investment in Bond Pets LLC
29th Aug 20197:00 amRNSAgronomics Participates in BlueNalu Fund Raise
28th Aug 20199:42 amRNSNew website launched
27th Aug 20191:21 pmRNSInvestee company Update: Blue Nalu, Inc
12th Aug 201912:51 pmRNSHolding(s) in Company
5th Aug 20197:00 amRNSHolding(s) in Company
31st Jul 20197:00 amRNSNet Asset Value(s)
29th Jul 20197:00 amRNSInvestment in Simply Foods, Inc. (New Age Meats)
5th Jul 20194:40 pmRNSSecond Price Monitoring Extn
5th Jul 20194:35 pmRNSPrice Monitoring Extension
3rd Jul 201912:58 pmRNSResult of Meeting
17th Jun 20192:05 pmRNSSecond Price Monitoring Extn
17th Jun 20192:00 pmRNSPrice Monitoring Extension
17th Jun 201911:00 amRNSPrice Monitoring Extension
13th Jun 20197:00 amRNSEquity Fundraise Closes at £4.5 million
10th Jun 20197:00 amRNSProposed Equity Fundraise
31st May 20199:30 amRNSBoard Appointments
16th Apr 20191:01 pmRNSResult of Meeting
10th Apr 20197:00 amRNSNet Asset Value
29th Mar 20197:00 amRNSCircular and Notice of General Meeting
29th Mar 20197:00 amRNSHalf-year Report
7th Feb 20197:00 amRNSNet Asset Value(s)
28th Dec 20182:20 pmRNSFinal Results
24th Oct 20187:00 amRNSNet Asset Value(s)
16th Aug 20187:00 amRNSInvestment in Blue Nalu, Inc.
18th Jul 20187:00 amRNSNet Asset Value(s)
28th Jun 20187:00 amRNSInvestee Company Update: Summit Therapeutics plc
23rd Apr 20187:00 amRNSNet Asset Value(s)
27th Mar 20189:30 amRNSHalf-year Report
9th Feb 201812:31 pmRNSResult of AGM
8th Feb 20187:00 amRNSChange of Adviser
22nd Jan 20187:00 amRNSNet Asset Value(s)
28th Dec 20174:49 pmRNSFinal Results
19th Oct 20177:00 amRNSNet Asset Value(s)
20th Jul 201711:00 amRNSNAV & Investment in AgeX Therapeutics Inc.
25th Apr 20177:00 amRNSRedemption of Interest in Magna Biopharma Fund
12th Apr 20177:00 amRNSNet Asset Value(s)
29th Mar 20177:00 amRNSHalf-year Report
10th Feb 20175:29 pmRNSResult of AGM
12th Jan 20177:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.